nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP2C9—brain cancer	0.372	1	CbGaD
Propofol—CYP1B1—Procarbazine—brain cancer	0.223	0.519	CbGbCtD
Propofol—UGT1A1—Etoposide—brain cancer	0.0397	0.0921	CbGbCtD
Propofol—CYP2D6—Lomustine—brain cancer	0.0307	0.0712	CbGbCtD
Propofol—CYP1A2—Carmustine—brain cancer	0.0304	0.0705	CbGbCtD
Propofol—CYP2D6—Hydroxyurea—brain cancer	0.0233	0.054	CbGbCtD
Propofol—CYP3A4—Temozolomide—brain cancer	0.0229	0.0533	CbGbCtD
Propofol—CYP3A4—Lomustine—brain cancer	0.0195	0.0453	CbGbCtD
Propofol—CYP2E1—Etoposide—brain cancer	0.0156	0.0361	CbGbCtD
Propofol—CYP2C8—Etoposide—brain cancer	0.0116	0.027	CbGbCtD
Propofol—CYP1A2—Etoposide—brain cancer	0.009	0.0209	CbGbCtD
Propofol—CYP3A4—Etoposide—brain cancer	0.00472	0.0109	CbGbCtD
Propofol—FAAH—telencephalic ventricle—brain cancer	0.0046	0.08	CbGeAlD
Propofol—FAAH—hindbrain—brain cancer	0.00217	0.0378	CbGeAlD
Propofol—Extravasation—Carboplatin—brain cancer	0.00184	0.024	CcSEcCtD
Propofol—Phlebitis—Carboplatin—brain cancer	0.00135	0.0177	CcSEcCtD
Propofol—Intracranial pressure increased—Carmustine—brain cancer	0.00134	0.0174	CcSEcCtD
Propofol—GABRA2—ganglion—brain cancer	0.00128	0.0222	CbGeAlD
Propofol—Thrombosis—Procarbazine—brain cancer	0.00126	0.0165	CcSEcCtD
Propofol—Nystagmus—Procarbazine—brain cancer	0.00125	0.0163	CcSEcCtD
Propofol—SCN2A—hindbrain—brain cancer	0.00125	0.0217	CbGeAlD
Propofol—FAAH—brainstem—brain cancer	0.00124	0.0216	CbGeAlD
Propofol—UGT1A6—endocrine gland—brain cancer	0.00113	0.0196	CbGeAlD
Propofol—FAAH—telencephalon—brain cancer	0.0011	0.0192	CbGeAlD
Propofol—Metabolic acidosis—Etoposide—brain cancer	0.00109	0.0143	CcSEcCtD
Propofol—Hypomagnesaemia—Hydroxyurea—brain cancer	0.00109	0.0142	CcSEcCtD
Propofol—GABRB2—hindbrain—brain cancer	0.00106	0.0184	CbGeAlD
Propofol—GABRA2—hindbrain—brain cancer	0.000968	0.0168	CbGeAlD
Propofol—UGT1A8—endocrine gland—brain cancer	0.000958	0.0167	CbGeAlD
Propofol—UGT1A8—head—brain cancer	0.000946	0.0165	CbGeAlD
Propofol—GABRA1—hindbrain—brain cancer	0.000936	0.0163	CbGeAlD
Propofol—FAAH—gonad—brain cancer	0.000921	0.016	CbGeAlD
Propofol—FAAH—pituitary gland—brain cancer	0.000899	0.0156	CbGeAlD
Propofol—FAAH—medulla oblongata—brain cancer	0.000867	0.0151	CbGeAlD
Propofol—Neuropathy—Procarbazine—brain cancer	0.000838	0.0109	CcSEcCtD
Propofol—FAAH—midbrain—brain cancer	0.000793	0.0138	CbGeAlD
Propofol—Thrombosis—Carmustine—brain cancer	0.000789	0.0103	CcSEcCtD
Propofol—FAAH—spinal cord—brain cancer	0.000774	0.0135	CbGeAlD
Propofol—Renal failure—Lomustine—brain cancer	0.000773	0.0101	CcSEcCtD
Propofol—Creatinine increased—Hydroxyurea—brain cancer	0.000725	0.00947	CcSEcCtD
Propofol—SCN2A—brainstem—brain cancer	0.000715	0.0124	CbGeAlD
Propofol—Haemoglobin—Lomustine—brain cancer	0.000709	0.00926	CcSEcCtD
Propofol—Haemorrhage—Lomustine—brain cancer	0.000706	0.00921	CcSEcCtD
Propofol—FAAH—endocrine gland—brain cancer	0.000696	0.0121	CbGeAlD
Propofol—Coagulopathy—Temozolomide—brain cancer	0.000693	0.00905	CcSEcCtD
Propofol—FAAH—head—brain cancer	0.000688	0.012	CbGeAlD
Propofol—Injection site pain—Carmustine—brain cancer	0.000684	0.00893	CcSEcCtD
Propofol—Visual impairment—Lomustine—brain cancer	0.00068	0.00888	CcSEcCtD
Propofol—Blood urea increased—Hydroxyurea—brain cancer	0.000652	0.00851	CcSEcCtD
Propofol—Diplopia—Procarbazine—brain cancer	0.000648	0.00846	CcSEcCtD
Propofol—Extravasation—Carmustine—brain cancer	0.00064	0.00835	CcSEcCtD
Propofol—SCN2A—telencephalon—brain cancer	0.000635	0.011	CbGeAlD
Propofol—FAAH—central nervous system—brain cancer	0.000628	0.0109	CbGeAlD
Propofol—Pulmonary oedema—Hydroxyurea—brain cancer	0.000615	0.00802	CcSEcCtD
Propofol—FAAH—cerebellum—brain cancer	0.000613	0.0107	CbGeAlD
Propofol—Thinking abnormal—Carmustine—brain cancer	0.00061	0.00796	CcSEcCtD
Propofol—UGT1A9—endocrine gland—brain cancer	0.000609	0.0106	CbGeAlD
Propofol—GABRB2—brainstem—brain cancer	0.000608	0.0106	CbGeAlD
Propofol—Leukocytosis—Carmustine—brain cancer	0.000594	0.00775	CcSEcCtD
Propofol—SCN4A—pituitary gland—brain cancer	0.000584	0.0102	CbGeAlD
Propofol—Laryngospasm—Etoposide—brain cancer	0.000578	0.00755	CcSEcCtD
Propofol—GABRA2—brainstem—brain cancer	0.000555	0.00966	CbGeAlD
Propofol—Respiratory failure—Temozolomide—brain cancer	0.000549	0.00717	CcSEcCtD
Propofol—Pancreatitis—Procarbazine—brain cancer	0.000549	0.00717	CcSEcCtD
Propofol—Sweating increased—Procarbazine—brain cancer	0.000545	0.00712	CcSEcCtD
Propofol—GABRB2—telencephalon—brain cancer	0.000539	0.00938	CbGeAlD
Propofol—GABRG2—telencephalon—brain cancer	0.000539	0.00938	CbGeAlD
Propofol—Tingling sensation—Etoposide—brain cancer	0.000537	0.00701	CcSEcCtD
Propofol—GABRA1—brainstem—brain cancer	0.000536	0.00933	CbGeAlD
Propofol—CYP2C18—endocrine gland—brain cancer	0.000532	0.00925	CbGeAlD
Propofol—Neuropathy—Carmustine—brain cancer	0.000524	0.00684	CcSEcCtD
Propofol—SCN2A—pituitary gland—brain cancer	0.000517	0.00899	CbGeAlD
Propofol—Apnoea—Etoposide—brain cancer	0.000509	0.00665	CcSEcCtD
Propofol—Neuropathy—Temozolomide—brain cancer	0.000506	0.00661	CcSEcCtD
Propofol—SCN2A—medulla oblongata—brain cancer	0.000499	0.00868	CbGeAlD
Propofol—FAAH—brain—brain cancer	0.000498	0.00867	CbGeAlD
Propofol—Extravasation—Etoposide—brain cancer	0.000495	0.00646	CcSEcCtD
Propofol—GABRA2—telencephalon—brain cancer	0.000493	0.00857	CbGeAlD
Propofol—Pain—Carboplatin—brain cancer	0.00049	0.0064	CcSEcCtD
Propofol—Neuropathy peripheral—Procarbazine—brain cancer	0.000489	0.00639	CcSEcCtD
Propofol—Abnormal vision—Carmustine—brain cancer	0.000487	0.00636	CcSEcCtD
Propofol—Mental disability—Carmustine—brain cancer	0.000484	0.00632	CcSEcCtD
Propofol—Sepsis—Carmustine—brain cancer	0.000484	0.00632	CcSEcCtD
Propofol—GABRA1—telencephalon—brain cancer	0.000476	0.00828	CbGeAlD
Propofol—Abnormal vision—Temozolomide—brain cancer	0.00047	0.00614	CcSEcCtD
Propofol—Phlebitis—Carmustine—brain cancer	0.00047	0.00614	CcSEcCtD
Propofol—Blood creatinine increased—Hydroxyurea—brain cancer	0.000469	0.00613	CcSEcCtD
Propofol—Mental disability—Temozolomide—brain cancer	0.000468	0.00611	CcSEcCtD
Propofol—Ear pain—Temozolomide—brain cancer	0.000459	0.00599	CcSEcCtD
Propofol—SCN2A—midbrain—brain cancer	0.000456	0.00793	CbGeAlD
Propofol—Body temperature increased—Carboplatin—brain cancer	0.000453	0.00592	CcSEcCtD
Propofol—Haemoglobin—Procarbazine—brain cancer	0.00045	0.00588	CcSEcCtD
Propofol—Eye pain—Carmustine—brain cancer	0.000449	0.00586	CcSEcCtD
Propofol—Haemorrhage—Procarbazine—brain cancer	0.000448	0.00585	CcSEcCtD
Propofol—SCN4A—head—brain cancer	0.000447	0.00777	CbGeAlD
Propofol—Hallucination—Procarbazine—brain cancer	0.000446	0.00582	CcSEcCtD
Propofol—SCN2A—spinal cord—brain cancer	0.000445	0.00774	CbGeAlD
Propofol—GABRG2—pituitary gland—brain cancer	0.000439	0.00764	CbGeAlD
Propofol—Eye pain—Temozolomide—brain cancer	0.000434	0.00566	CcSEcCtD
Propofol—Pancreatitis—Hydroxyurea—brain cancer	0.000425	0.00555	CcSEcCtD
Propofol—GABRB2—medulla oblongata—brain cancer	0.000424	0.00737	CbGeAlD
Propofol—GABRG2—medulla oblongata—brain cancer	0.000424	0.00737	CbGeAlD
Propofol—UGT1A1—endocrine gland—brain cancer	0.000417	0.00726	CbGeAlD
Propofol—Flushing—Procarbazine—brain cancer	0.000416	0.00543	CcSEcCtD
Propofol—GABRB3—telencephalon—brain cancer	0.000414	0.0072	CbGeAlD
Propofol—CYP2D6—hindbrain—brain cancer	0.00041	0.00713	CbGeAlD
Propofol—CYP1B1—telencephalon—brain cancer	0.000409	0.00711	CbGeAlD
Propofol—SCN4A—central nervous system—brain cancer	0.000408	0.00709	CbGeAlD
Propofol—Neuropathy—Etoposide—brain cancer	0.000405	0.00529	CcSEcCtD
Propofol—Diplopia—Carmustine—brain cancer	0.000405	0.00529	CcSEcCtD
Propofol—Chills—Procarbazine—brain cancer	0.000402	0.00525	CcSEcCtD
Propofol—SCN2A—endocrine gland—brain cancer	0.0004	0.00696	CbGeAlD
Propofol—Arrhythmia—Procarbazine—brain cancer	0.0004	0.00523	CcSEcCtD
Propofol—Body temperature increased—Lomustine—brain cancer	0.000396	0.00517	CcSEcCtD
Propofol—SCN2A—head—brain cancer	0.000395	0.00688	CbGeAlD
Propofol—Diplopia—Temozolomide—brain cancer	0.000392	0.00511	CcSEcCtD
Propofol—GABRB2—midbrain—brain cancer	0.000387	0.00674	CbGeAlD
Propofol—GABRG2—midbrain—brain cancer	0.000387	0.00674	CbGeAlD
Propofol—Affect lability—Temozolomide—brain cancer	0.000385	0.00503	CcSEcCtD
Propofol—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000379	0.00494	CcSEcCtD
Propofol—GABRB2—spinal cord—brain cancer	0.000378	0.00657	CbGeAlD
Propofol—GABRG2—spinal cord—brain cancer	0.000378	0.00657	CbGeAlD
Propofol—Sepsis—Etoposide—brain cancer	0.000375	0.00489	CcSEcCtD
Propofol—GABRA1—medulla oblongata—brain cancer	0.000374	0.00651	CbGeAlD
Propofol—Mood swings—Temozolomide—brain cancer	0.000371	0.00484	CcSEcCtD
Propofol—Tremor—Procarbazine—brain cancer	0.000365	0.00477	CcSEcCtD
Propofol—Dehydration—Temozolomide—brain cancer	0.000364	0.00475	CcSEcCtD
Propofol—Phlebitis—Etoposide—brain cancer	0.000364	0.00475	CcSEcCtD
Propofol—SCN2A—central nervous system—brain cancer	0.000361	0.00628	CbGeAlD
Propofol—SCN2A—cerebellum—brain cancer	0.000353	0.00613	CbGeAlD
Propofol—Syncope—Procarbazine—brain cancer	0.00035	0.00457	CcSEcCtD
Propofol—Haemoglobin—Hydroxyurea—brain cancer	0.000348	0.00455	CcSEcCtD
Propofol—Haemorrhage—Hydroxyurea—brain cancer	0.000347	0.00453	CcSEcCtD
Propofol—GABRB3—gonad—brain cancer	0.000346	0.00601	CbGeAlD
Propofol—Hallucination—Hydroxyurea—brain cancer	0.000345	0.0045	CcSEcCtD
Propofol—Loss of consciousness—Procarbazine—brain cancer	0.000343	0.00448	CcSEcCtD
Propofol—GABRA1—midbrain—brain cancer	0.000342	0.00595	CbGeAlD
Propofol—CYP1B1—gonad—brain cancer	0.000341	0.00593	CbGeAlD
Propofol—Cough—Procarbazine—brain cancer	0.00034	0.00444	CcSEcCtD
Propofol—Convulsion—Procarbazine—brain cancer	0.000338	0.00441	CcSEcCtD
Propofol—GABRB3—pituitary gland—brain cancer	0.000337	0.00586	CbGeAlD
Propofol—Hypertension—Procarbazine—brain cancer	0.000337	0.0044	CcSEcCtD
Propofol—GABRG2—head—brain cancer	0.000336	0.00584	CbGeAlD
Propofol—GABRB2—head—brain cancer	0.000336	0.00584	CbGeAlD
Propofol—GABRA1—spinal cord—brain cancer	0.000334	0.0058	CbGeAlD
Propofol—CYP1B1—pituitary gland—brain cancer	0.000333	0.00579	CbGeAlD
Propofol—Myalgia—Procarbazine—brain cancer	0.000332	0.00434	CcSEcCtD
Propofol—Anxiety—Procarbazine—brain cancer	0.000331	0.00432	CcSEcCtD
Propofol—Sweating increased—Temozolomide—brain cancer	0.00033	0.0043	CcSEcCtD
Propofol—GABRB3—medulla oblongata—brain cancer	0.000325	0.00566	CbGeAlD
Propofol—Dry mouth—Procarbazine—brain cancer	0.000325	0.00424	CcSEcCtD
Propofol—Anaphylactoid reaction—Etoposide—brain cancer	0.000324	0.00423	CcSEcCtD
Propofol—SCN4A—brain—brain cancer	0.000324	0.00563	CbGeAlD
Propofol—Cardiac failure—Etoposide—brain cancer	0.000321	0.00419	CcSEcCtD
Propofol—Confusional state—Procarbazine—brain cancer	0.000321	0.00419	CcSEcCtD
Propofol—Vomiting—Lomustine—brain cancer	0.000319	0.00416	CcSEcCtD
Propofol—Oedema—Procarbazine—brain cancer	0.000318	0.00416	CcSEcCtD
Propofol—Hyperglycaemia—Carmustine—brain cancer	0.000316	0.00412	CcSEcCtD
Propofol—Shock—Procarbazine—brain cancer	0.000313	0.00409	CcSEcCtD
Propofol—Depression—Carmustine—brain cancer	0.000311	0.00407	CcSEcCtD
Propofol—Chills—Hydroxyurea—brain cancer	0.000311	0.00406	CcSEcCtD
Propofol—Tachycardia—Procarbazine—brain cancer	0.000311	0.00406	CcSEcCtD
Propofol—CYP2A6—cerebellum—brain cancer	0.00031	0.00539	CbGeAlD
Propofol—Hyperhidrosis—Procarbazine—brain cancer	0.000308	0.00402	CcSEcCtD
Propofol—Renal failure—Carmustine—brain cancer	0.000307	0.00401	CcSEcCtD
Propofol—GABRA2—head—brain cancer	0.000307	0.00534	CbGeAlD
Propofol—GABRB2—central nervous system—brain cancer	0.000306	0.00533	CbGeAlD
Propofol—GABRG2—central nervous system—brain cancer	0.000306	0.00533	CbGeAlD
Propofol—Neuropathy peripheral—Carmustine—brain cancer	0.000306	0.004	CcSEcCtD
Propofol—Hyperglycaemia—Temozolomide—brain cancer	0.000305	0.00399	CcSEcCtD
Propofol—Erythema—Hydroxyurea—brain cancer	0.000302	0.00394	CcSEcCtD
Propofol—Depression—Temozolomide—brain cancer	0.000301	0.00393	CcSEcCtD
Propofol—GABRB2—cerebellum—brain cancer	0.0003	0.00521	CbGeAlD
Propofol—GABRG2—cerebellum—brain cancer	0.0003	0.00521	CbGeAlD
Propofol—Cardiac arrest—Etoposide—brain cancer	0.000298	0.00389	CcSEcCtD
Propofol—Nausea—Lomustine—brain cancer	0.000298	0.00389	CcSEcCtD
Propofol—Hypotension—Procarbazine—brain cancer	0.000297	0.00388	CcSEcCtD
Propofol—GABRB3—midbrain—brain cancer	0.000297	0.00517	CbGeAlD
Propofol—GABRA1—head—brain cancer	0.000296	0.00516	CbGeAlD
Propofol—Neuropathy peripheral—Temozolomide—brain cancer	0.000296	0.00386	CcSEcCtD
Propofol—GABRB3—spinal cord—brain cancer	0.00029	0.00505	CbGeAlD
Propofol—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00029	0.00379	CcSEcCtD
Propofol—Insomnia—Procarbazine—brain cancer	0.000288	0.00376	CcSEcCtD
Propofol—SCN2A—brain—brain cancer	0.000286	0.00498	CbGeAlD
Propofol—Paraesthesia—Procarbazine—brain cancer	0.000286	0.00373	CcSEcCtD
Propofol—Somnolence—Procarbazine—brain cancer	0.000283	0.00369	CcSEcCtD
Propofol—Cramp muscle—Etoposide—brain cancer	0.000282	0.00368	CcSEcCtD
Propofol—Haemoglobin—Carmustine—brain cancer	0.000282	0.00368	CcSEcCtD
Propofol—Haemorrhage—Carmustine—brain cancer	0.00028	0.00366	CcSEcCtD
Propofol—GABRA2—central nervous system—brain cancer	0.00028	0.00487	CbGeAlD
Propofol—Hallucination—Carmustine—brain cancer	0.000279	0.00364	CcSEcCtD
Propofol—Fatigue—Procarbazine—brain cancer	0.000274	0.00358	CcSEcCtD
Propofol—GABRA2—cerebellum—brain cancer	0.000274	0.00476	CbGeAlD
Propofol—Haemoglobin—Temozolomide—brain cancer	0.000272	0.00355	CcSEcCtD
Propofol—Pain—Procarbazine—brain cancer	0.000272	0.00355	CcSEcCtD
Propofol—Haemorrhage—Temozolomide—brain cancer	0.000271	0.00354	CcSEcCtD
Propofol—GABRA1—central nervous system—brain cancer	0.000271	0.00471	CbGeAlD
Propofol—Visual impairment—Carmustine—brain cancer	0.00027	0.00353	CcSEcCtD
Propofol—Hallucination—Temozolomide—brain cancer	0.000269	0.00352	CcSEcCtD
Propofol—Pharyngitis—Temozolomide—brain cancer	0.000269	0.00351	CcSEcCtD
Propofol—Bronchospasm—Etoposide—brain cancer	0.000266	0.00348	CcSEcCtD
Propofol—GABRA1—cerebellum—brain cancer	0.000264	0.0046	CbGeAlD
Propofol—Sweating increased—Etoposide—brain cancer	0.000264	0.00344	CcSEcCtD
Propofol—CYP2E1—telencephalon—brain cancer	0.000263	0.00458	CbGeAlD
Propofol—Feeling abnormal—Procarbazine—brain cancer	0.000262	0.00342	CcSEcCtD
Propofol—Convulsion—Hydroxyurea—brain cancer	0.000261	0.00341	CcSEcCtD
Propofol—GABRB3—endocrine gland—brain cancer	0.000261	0.00454	CbGeAlD
Propofol—Visual impairment—Temozolomide—brain cancer	0.000261	0.00341	CcSEcCtD
Propofol—Flushing—Carmustine—brain cancer	0.00026	0.0034	CcSEcCtD
Propofol—GABRB3—head—brain cancer	0.000258	0.00448	CbGeAlD
Propofol—CYP1B1—endocrine gland—brain cancer	0.000258	0.00448	CbGeAlD
Propofol—CYP2C8—pituitary gland—brain cancer	0.000255	0.00443	CbGeAlD
Propofol—CYP1B1—head—brain cancer	0.000254	0.00443	CbGeAlD
Propofol—Urticaria—Procarbazine—brain cancer	0.000253	0.0033	CcSEcCtD
Propofol—Tinnitus—Temozolomide—brain cancer	0.000253	0.0033	CcSEcCtD
Propofol—Abdominal pain—Procarbazine—brain cancer	0.000252	0.00329	CcSEcCtD
Propofol—Body temperature increased—Procarbazine—brain cancer	0.000252	0.00329	CcSEcCtD
Propofol—CYP2A6—brain—brain cancer	0.000252	0.00438	CbGeAlD
Propofol—Flushing—Temozolomide—brain cancer	0.000251	0.00328	CcSEcCtD
Propofol—Arrhythmia—Carmustine—brain cancer	0.00025	0.00327	CcSEcCtD
Propofol—Oedema—Hydroxyurea—brain cancer	0.000246	0.00322	CcSEcCtD
Propofol—Erythema—Carmustine—brain cancer	0.000244	0.00319	CcSEcCtD
Propofol—GABRB2—brain—brain cancer	0.000243	0.00423	CbGeAlD
Propofol—GABRG2—brain—brain cancer	0.000243	0.00423	CbGeAlD
Propofol—Chills—Temozolomide—brain cancer	0.000243	0.00317	CcSEcCtD
Propofol—Acute coronary syndrome—Etoposide—brain cancer	0.000238	0.00311	CcSEcCtD
Propofol—Renal failure—Etoposide—brain cancer	0.000237	0.0031	CcSEcCtD
Propofol—Myocardial infarction—Etoposide—brain cancer	0.000237	0.00309	CcSEcCtD
Propofol—Neuropathy peripheral—Etoposide—brain cancer	0.000237	0.00309	CcSEcCtD
Propofol—Erythema—Temozolomide—brain cancer	0.000236	0.00308	CcSEcCtD
Propofol—GABRB3—central nervous system—brain cancer	0.000235	0.00409	CbGeAlD
Propofol—CYP2D6—brainstem—brain cancer	0.000235	0.00409	CbGeAlD
Propofol—CYP2B6—gonad—brain cancer	0.000234	0.00407	CbGeAlD
Propofol—CYP1B1—central nervous system—brain cancer	0.000232	0.00404	CbGeAlD
Propofol—Dysgeusia—Temozolomide—brain cancer	0.000231	0.00302	CcSEcCtD
Propofol—GABRB3—cerebellum—brain cancer	0.00023	0.004	CbGeAlD
Propofol—Tremor—Carmustine—brain cancer	0.000229	0.00298	CcSEcCtD
Propofol—Asthenia—Procarbazine—brain cancer	0.000228	0.00298	CcSEcCtD
Propofol—CYP1B1—cerebellum—brain cancer	0.000227	0.00395	CbGeAlD
Propofol—CYP2C19—endocrine gland—brain cancer	0.000226	0.00393	CbGeAlD
Propofol—Pruritus—Procarbazine—brain cancer	0.000225	0.00294	CcSEcCtD
Propofol—Agitation—Carmustine—brain cancer	0.000224	0.00293	CcSEcCtD
Propofol—GABRA2—brain—brain cancer	0.000222	0.00387	CbGeAlD
Propofol—Tremor—Temozolomide—brain cancer	0.000221	0.00288	CcSEcCtD
Propofol—Dyspnoea—Hydroxyurea—brain cancer	0.00022	0.00287	CcSEcCtD
Propofol—Somnolence—Hydroxyurea—brain cancer	0.000219	0.00286	CcSEcCtD
Propofol—Diarrhoea—Procarbazine—brain cancer	0.000218	0.00284	CcSEcCtD
Propofol—Agitation—Temozolomide—brain cancer	0.000217	0.00283	CcSEcCtD
Propofol—Angioedema—Temozolomide—brain cancer	0.000215	0.00281	CcSEcCtD
Propofol—GABRA1—brain—brain cancer	0.000215	0.00374	CbGeAlD
Propofol—Fatigue—Hydroxyurea—brain cancer	0.000212	0.00277	CcSEcCtD
Propofol—Convulsion—Carmustine—brain cancer	0.000211	0.00276	CcSEcCtD
Propofol—Hypertension—Carmustine—brain cancer	0.000211	0.00275	CcSEcCtD
Propofol—Pain—Hydroxyurea—brain cancer	0.000211	0.00275	CcSEcCtD
Propofol—Dizziness—Procarbazine—brain cancer	0.00021	0.00275	CcSEcCtD
Propofol—CYP2D6—telencephalon—brain cancer	0.000209	0.00363	CbGeAlD
Propofol—Myalgia—Carmustine—brain cancer	0.000208	0.00271	CcSEcCtD
Propofol—Chest pain—Carmustine—brain cancer	0.000208	0.00271	CcSEcCtD
Propofol—Anxiety—Carmustine—brain cancer	0.000207	0.0027	CcSEcCtD
Propofol—CYP2E1—medulla oblongata—brain cancer	0.000207	0.0036	CbGeAlD
Propofol—Cough—Temozolomide—brain cancer	0.000206	0.00269	CcSEcCtD
Propofol—Convulsion—Temozolomide—brain cancer	0.000204	0.00267	CcSEcCtD
Propofol—Hypertension—Temozolomide—brain cancer	0.000204	0.00266	CcSEcCtD
Propofol—Feeling abnormal—Hydroxyurea—brain cancer	0.000203	0.00265	CcSEcCtD
Propofol—Vomiting—Procarbazine—brain cancer	0.000202	0.00264	CcSEcCtD
Propofol—Flushing—Etoposide—brain cancer	0.000201	0.00263	CcSEcCtD
Propofol—ALB—brain—brain cancer	0.000201	0.0035	CbGeAlD
Propofol—Confusional state—Carmustine—brain cancer	0.000201	0.00262	CcSEcCtD
Propofol—Myalgia—Temozolomide—brain cancer	0.000201	0.00262	CcSEcCtD
Propofol—Rash—Procarbazine—brain cancer	0.000201	0.00262	CcSEcCtD
Propofol—Dermatitis—Procarbazine—brain cancer	0.0002	0.00262	CcSEcCtD
Propofol—Anxiety—Temozolomide—brain cancer	0.0002	0.00261	CcSEcCtD
Propofol—Headache—Procarbazine—brain cancer	0.000199	0.0026	CcSEcCtD
Propofol—Oedema—Carmustine—brain cancer	0.000199	0.0026	CcSEcCtD
Propofol—CYP2C8—endocrine gland—brain cancer	0.000197	0.00343	CbGeAlD
Propofol—Dry mouth—Temozolomide—brain cancer	0.000196	0.00256	CcSEcCtD
Propofol—Body temperature increased—Hydroxyurea—brain cancer	0.000195	0.00254	CcSEcCtD
Propofol—Chills—Etoposide—brain cancer	0.000194	0.00254	CcSEcCtD
Propofol—Tachycardia—Carmustine—brain cancer	0.000194	0.00254	CcSEcCtD
Propofol—Confusional state—Temozolomide—brain cancer	0.000194	0.00253	CcSEcCtD
Propofol—Anaphylactic shock—Temozolomide—brain cancer	0.000192	0.00251	CcSEcCtD
Propofol—Oedema—Temozolomide—brain cancer	0.000192	0.00251	CcSEcCtD
Propofol—Nausea—Procarbazine—brain cancer	0.000189	0.00247	CcSEcCtD
Propofol—GABRB3—brain—brain cancer	0.000187	0.00325	CbGeAlD
Propofol—Hypotension—Carmustine—brain cancer	0.000186	0.00243	CcSEcCtD
Propofol—Hyperhidrosis—Temozolomide—brain cancer	0.000186	0.00243	CcSEcCtD
Propofol—Dysgeusia—Etoposide—brain cancer	0.000185	0.00241	CcSEcCtD
Propofol—CYP1A2—endocrine gland—brain cancer	0.000185	0.00321	CbGeAlD
Propofol—CYP2E1—spinal cord—brain cancer	0.000185	0.00321	CbGeAlD
Propofol—CYP1B1—brain—brain cancer	0.000184	0.00321	CbGeAlD
Propofol—CYP1A1—endocrine gland—brain cancer	0.000182	0.00317	CbGeAlD
Propofol—Musculoskeletal discomfort—Carmustine—brain cancer	0.000181	0.00237	CcSEcCtD
Propofol—Muscle spasms—Etoposide—brain cancer	0.000181	0.00237	CcSEcCtD
Propofol—Insomnia—Carmustine—brain cancer	0.00018	0.00235	CcSEcCtD
Propofol—CYP1A1—head—brain cancer	0.00018	0.00313	CbGeAlD
Propofol—Paraesthesia—Carmustine—brain cancer	0.000179	0.00233	CcSEcCtD
Propofol—Dyspnoea—Carmustine—brain cancer	0.000178	0.00232	CcSEcCtD
Propofol—CYP2B6—endocrine gland—brain cancer	0.000177	0.00308	CbGeAlD
Propofol—Somnolence—Carmustine—brain cancer	0.000177	0.00231	CcSEcCtD
Propofol—Asthenia—Hydroxyurea—brain cancer	0.000177	0.00231	CcSEcCtD
Propofol—CYP2C9—endocrine gland—brain cancer	0.000175	0.00305	CbGeAlD
Propofol—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000175	0.00229	CcSEcCtD
Propofol—CYP2B6—head—brain cancer	0.000175	0.00304	CbGeAlD
Propofol—Insomnia—Temozolomide—brain cancer	0.000174	0.00227	CcSEcCtD
Propofol—Paraesthesia—Temozolomide—brain cancer	0.000173	0.00226	CcSEcCtD
Propofol—Dyspnoea—Temozolomide—brain cancer	0.000172	0.00224	CcSEcCtD
Propofol—Somnolence—Temozolomide—brain cancer	0.000171	0.00223	CcSEcCtD
Propofol—Pain—Carmustine—brain cancer	0.00017	0.00222	CcSEcCtD
Propofol—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00017	0.00269	CbGpPWpGaD
Propofol—Diarrhoea—Hydroxyurea—brain cancer	0.000169	0.0022	CcSEcCtD
Propofol—CYP2E1—endocrine gland—brain cancer	0.000166	0.00289	CbGeAlD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000166	0.00263	CbGpPWpGaD
Propofol—Fatigue—Temozolomide—brain cancer	0.000166	0.00217	CcSEcCtD
Propofol—Loss of consciousness—Etoposide—brain cancer	0.000166	0.00217	CcSEcCtD
Propofol—Cough—Etoposide—brain cancer	0.000165	0.00215	CcSEcCtD
Propofol—Pain—Temozolomide—brain cancer	0.000165	0.00215	CcSEcCtD
Propofol—CYP1A1—central nervous system—brain cancer	0.000164	0.00286	CbGeAlD
Propofol—Feeling abnormal—Carmustine—brain cancer	0.000164	0.00214	CcSEcCtD
Propofol—CYP2E1—head—brain cancer	0.000164	0.00285	CbGeAlD
Propofol—Convulsion—Etoposide—brain cancer	0.000163	0.00213	CcSEcCtD
Propofol—Hypertension—Etoposide—brain cancer	0.000163	0.00213	CcSEcCtD
Propofol—Dizziness—Hydroxyurea—brain cancer	0.000163	0.00213	CcSEcCtD
Propofol—CYP1B1—Biological oxidations—CYP2C9—brain cancer	0.000161	0.00255	CbGpPWpGaD
Propofol—Chest pain—Etoposide—brain cancer	0.000161	0.0021	CcSEcCtD
Propofol—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.00016	0.00253	CbGpPWpGaD
Propofol—CYP2B6—central nervous system—brain cancer	0.00016	0.00278	CbGeAlD
Propofol—CYP1B1—Metapathway biotransformation—CYP2C9—brain cancer	0.000159	0.00252	CbGpPWpGaD
Propofol—Feeling abnormal—Temozolomide—brain cancer	0.000159	0.00207	CcSEcCtD
Propofol—Body temperature increased—Carmustine—brain cancer	0.000157	0.00206	CcSEcCtD
Propofol—Abdominal pain—Carmustine—brain cancer	0.000157	0.00206	CcSEcCtD
Propofol—Vomiting—Hydroxyurea—brain cancer	0.000157	0.00205	CcSEcCtD
Propofol—Rash—Hydroxyurea—brain cancer	0.000155	0.00203	CcSEcCtD
Propofol—Confusional state—Etoposide—brain cancer	0.000155	0.00203	CcSEcCtD
Propofol—Dermatitis—Hydroxyurea—brain cancer	0.000155	0.00203	CcSEcCtD
Propofol—Headache—Hydroxyurea—brain cancer	0.000154	0.00202	CcSEcCtD
Propofol—Anaphylactic shock—Etoposide—brain cancer	0.000154	0.00201	CcSEcCtD
Propofol—Urticaria—Temozolomide—brain cancer	0.000153	0.002	CcSEcCtD
Propofol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000153	0.00242	CbGpPWpGaD
Propofol—Abdominal pain—Temozolomide—brain cancer	0.000152	0.00199	CcSEcCtD
Propofol—Body temperature increased—Temozolomide—brain cancer	0.000152	0.00199	CcSEcCtD
Propofol—Tachycardia—Etoposide—brain cancer	0.00015	0.00196	CcSEcCtD
Propofol—CYP2E1—central nervous system—brain cancer	0.00015	0.0026	CbGeAlD
Propofol—Hyperhidrosis—Etoposide—brain cancer	0.000149	0.00194	CcSEcCtD
Propofol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000147	0.00233	CbGpPWpGaD
Propofol—CYP2E1—cerebellum—brain cancer	0.000146	0.00255	CbGeAlD
Propofol—Nausea—Hydroxyurea—brain cancer	0.000146	0.00191	CcSEcCtD
Propofol—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000145	0.0023	CbGpPWpGaD
Propofol—Hypotension—Etoposide—brain cancer	0.000144	0.00188	CcSEcCtD
Propofol—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000144	0.00228	CbGpPWpGaD
Propofol—Asthenia—Carmustine—brain cancer	0.000143	0.00187	CcSEcCtD
Propofol—UGT1A9—PPAR Alpha Pathway—CCND1—brain cancer	0.000142	0.00226	CbGpPWpGaD
Propofol—CYP2C8—brain—brain cancer	0.000141	0.00246	CbGeAlD
Propofol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000141	0.00224	CbGpPWpGaD
Propofol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000141	0.00223	CbGpPWpGaD
Propofol—Paraesthesia—Etoposide—brain cancer	0.000138	0.00181	CcSEcCtD
Propofol—Asthenia—Temozolomide—brain cancer	0.000138	0.0018	CcSEcCtD
Propofol—Dyspnoea—Etoposide—brain cancer	0.000137	0.00179	CcSEcCtD
Propofol—Somnolence—Etoposide—brain cancer	0.000137	0.00179	CcSEcCtD
Propofol—Diarrhoea—Carmustine—brain cancer	0.000136	0.00178	CcSEcCtD
Propofol—Pruritus—Temozolomide—brain cancer	0.000136	0.00178	CcSEcCtD
Propofol—CYP3A4—endocrine gland—brain cancer	0.000134	0.00233	CbGeAlD
Propofol—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000133	0.00211	CbGpPWpGaD
Propofol—Fatigue—Etoposide—brain cancer	0.000133	0.00173	CcSEcCtD
Propofol—Dizziness—Carmustine—brain cancer	0.000132	0.00172	CcSEcCtD
Propofol—Pain—Etoposide—brain cancer	0.000132	0.00172	CcSEcCtD
Propofol—Diarrhoea—Temozolomide—brain cancer	0.000132	0.00172	CcSEcCtD
Propofol—CYP2D6—endocrine gland—brain cancer	0.000132	0.00229	CbGeAlD
Propofol—CYP1A1—brain—brain cancer	0.00013	0.00227	CbGeAlD
Propofol—CYP2D6—head—brain cancer	0.00013	0.00226	CbGeAlD
Propofol—Dizziness—Temozolomide—brain cancer	0.000127	0.00166	CcSEcCtD
Propofol—Feeling abnormal—Etoposide—brain cancer	0.000127	0.00166	CcSEcCtD
Propofol—CYP2B6—brain—brain cancer	0.000127	0.0022	CbGeAlD
Propofol—Vomiting—Carmustine—brain cancer	0.000127	0.00165	CcSEcCtD
Propofol—Rash—Carmustine—brain cancer	0.000126	0.00164	CcSEcCtD
Propofol—Dermatitis—Carmustine—brain cancer	0.000125	0.00164	CcSEcCtD
Propofol—Headache—Carmustine—brain cancer	0.000125	0.00163	CcSEcCtD
Propofol—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000123	0.00195	CbGpPWpGaD
Propofol—Vomiting—Temozolomide—brain cancer	0.000122	0.0016	CcSEcCtD
Propofol—Urticaria—Etoposide—brain cancer	0.000122	0.0016	CcSEcCtD
Propofol—Body temperature increased—Etoposide—brain cancer	0.000122	0.00159	CcSEcCtD
Propofol—Abdominal pain—Etoposide—brain cancer	0.000122	0.00159	CcSEcCtD
Propofol—Rash—Temozolomide—brain cancer	0.000121	0.00158	CcSEcCtD
Propofol—Dermatitis—Temozolomide—brain cancer	0.000121	0.00158	CcSEcCtD
Propofol—Headache—Temozolomide—brain cancer	0.000121	0.00157	CcSEcCtD
Propofol—CYP3A4—central nervous system—brain cancer	0.00012	0.0021	CbGeAlD
Propofol—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000119	0.00189	CbGpPWpGaD
Propofol—CYP2E1—brain—brain cancer	0.000119	0.00207	CbGeAlD
Propofol—SCN2A—Axon guidance—TRPC6—brain cancer	0.000119	0.00188	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—TRPC6—brain cancer	0.000119	0.00188	CbGpPWpGaD
Propofol—CYP2D6—central nervous system—brain cancer	0.000119	0.00206	CbGeAlD
Propofol—Nausea—Carmustine—brain cancer	0.000118	0.00154	CcSEcCtD
Propofol—CYP2D6—cerebellum—brain cancer	0.000116	0.00202	CbGeAlD
Propofol—GABRB2—Ion channel transport—TRPC6—brain cancer	0.000116	0.00183	CbGpPWpGaD
Propofol—Nausea—Temozolomide—brain cancer	0.000114	0.00149	CcSEcCtD
Propofol—UGT1A9—PPAR Alpha Pathway—MYC—brain cancer	0.000114	0.00181	CbGpPWpGaD
Propofol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000113	0.0018	CbGpPWpGaD
Propofol—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000112	0.00177	CbGpPWpGaD
Propofol—Asthenia—Etoposide—brain cancer	0.00011	0.00144	CcSEcCtD
Propofol—Pruritus—Etoposide—brain cancer	0.000109	0.00142	CcSEcCtD
Propofol—GABRA2—Ion channel transport—TRPC6—brain cancer	0.000108	0.00172	CbGpPWpGaD
Propofol—GABRB3—Ion channel transport—TRPC6—brain cancer	0.000108	0.0017	CbGpPWpGaD
Propofol—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000107	0.0017	CbGpPWpGaD
Propofol—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000106	0.00168	CbGpPWpGaD
Propofol—GABRG2—Ion channel transport—TRPC6—brain cancer	0.000106	0.00167	CbGpPWpGaD
Propofol—Diarrhoea—Etoposide—brain cancer	0.000105	0.00138	CcSEcCtD
Propofol—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000105	0.00167	CbGpPWpGaD
Propofol—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000104	0.00164	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000102	0.00162	CbGpPWpGaD
Propofol—Dizziness—Etoposide—brain cancer	0.000102	0.00133	CcSEcCtD
Propofol—CYP1A1—Biological oxidations—CYP2C9—brain cancer	9.92e-05	0.00157	CbGpPWpGaD
Propofol—Vomiting—Etoposide—brain cancer	9.79e-05	0.00128	CcSEcCtD
Propofol—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	9.78e-05	0.00155	CbGpPWpGaD
Propofol—Rash—Etoposide—brain cancer	9.71e-05	0.00127	CcSEcCtD
Propofol—Dermatitis—Etoposide—brain cancer	9.7e-05	0.00127	CcSEcCtD
Propofol—Headache—Etoposide—brain cancer	9.65e-05	0.00126	CcSEcCtD
Propofol—CYP3A4—Irinotecan Pathway—APC—brain cancer	9.63e-05	0.00152	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor—RELA—brain cancer	9.58e-05	0.00152	CbGpPWpGaD
Propofol—CYP2D6—brain—brain cancer	9.41e-05	0.00164	CbGeAlD
Propofol—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	9.31e-05	0.00148	CbGpPWpGaD
Propofol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	9.26e-05	0.00147	CbGpPWpGaD
Propofol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	9.26e-05	0.00147	CbGpPWpGaD
Propofol—GABRA1—Ion channel transport—TRPC6—brain cancer	9.24e-05	0.00146	CbGpPWpGaD
Propofol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.19e-05	0.00146	CbGpPWpGaD
Propofol—Nausea—Etoposide—brain cancer	9.15e-05	0.00119	CcSEcCtD
Propofol—UGT1A8—Metabolism—CYP2C9—brain cancer	9.13e-05	0.00145	CbGpPWpGaD
Propofol—CYP2C8—Biological oxidations—CYP2C9—brain cancer	9.09e-05	0.00144	CbGpPWpGaD
Propofol—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	8.97e-05	0.00142	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—S100A10—brain cancer	8.71e-05	0.00138	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	8.63e-05	0.00137	CbGpPWpGaD
Propofol—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	8.57e-05	0.00136	CbGpPWpGaD
Propofol—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	8.54e-05	0.00135	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—TRPC6—brain cancer	8.47e-05	0.00134	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—TRPC6—brain cancer	8.47e-05	0.00134	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—S100A10—brain cancer	8.16e-05	0.00129	CbGpPWpGaD
Propofol—CYP2C19—Biological oxidations—CYP2C9—brain cancer	8.12e-05	0.00129	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—S100A10—brain cancer	8.11e-05	0.00128	CbGpPWpGaD
Propofol—SCN2A—L1CAM interactions—EGFR—brain cancer	8.05e-05	0.00127	CbGpPWpGaD
Propofol—SCN4A—L1CAM interactions—EGFR—brain cancer	8.05e-05	0.00127	CbGpPWpGaD
Propofol—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	8.01e-05	0.00127	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—S100A10—brain cancer	7.96e-05	0.00126	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—ESR2—brain cancer	7.9e-05	0.00125	CbGpPWpGaD
Propofol—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	7.84e-05	0.00124	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—BSG—brain cancer	7.76e-05	0.00123	CbGpPWpGaD
Propofol—CYP2D6—Biological oxidations—CYP2C9—brain cancer	7.47e-05	0.00118	CbGpPWpGaD
Propofol—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	7.36e-05	0.00117	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	7.34e-05	0.00116	CbGpPWpGaD
Propofol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	7.08e-05	0.00112	CbGpPWpGaD
Propofol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	7.08e-05	0.00112	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—SPP1—brain cancer	7.04e-05	0.00112	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—SOD2—brain cancer	6.97e-05	0.0011	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—S100A10—brain cancer	6.96e-05	0.0011	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor—MYC—brain cancer	6.75e-05	0.00107	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—IDH1—brain cancer	6.68e-05	0.00106	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—CYP2C9—brain cancer	6.66e-05	0.00105	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.63e-05	0.00105	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	6.6e-05	0.00105	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	6.6e-05	0.00105	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	6.52e-05	0.00103	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—IRS2—brain cancer	6.37e-05	0.00101	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—CYP2C9—brain cancer	6.33e-05	0.001	CbGpPWpGaD
Propofol—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	6.24e-05	0.000988	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.19e-05	0.00098	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—HES1—brain cancer	6.13e-05	0.000971	CbGpPWpGaD
Propofol—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	5.98e-05	0.000946	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.9e-05	0.000935	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—BSG—brain cancer	5.66e-05	0.000897	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—APC—brain cancer	5.63e-05	0.000891	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—SOD2—brain cancer	5.54e-05	0.000877	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—HES1—brain cancer	5.46e-05	0.000865	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—HES1—brain cancer	5.46e-05	0.000865	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.32e-05	0.000842	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—ENO2—brain cancer	5.28e-05	0.000836	CbGpPWpGaD
Propofol—ALB—Vitamin B12 Metabolism—RELA—brain cancer	4.95e-05	0.000785	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.88e-05	0.000773	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—IDH1—brain cancer	4.87e-05	0.000771	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.85e-05	0.000768	CbGpPWpGaD
Propofol—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.81e-05	0.000762	CbGpPWpGaD
Propofol—ALB—Hemostasis—MPL—brain cancer	4.8e-05	0.00076	CbGpPWpGaD
Propofol—ALB—Hemostasis—S100A10—brain cancer	4.6e-05	0.000729	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.52e-05	0.000716	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.52e-05	0.000715	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—RELA—brain cancer	4.4e-05	0.000696	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—ERBB2—brain cancer	4.39e-05	0.000695	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—ERBB2—brain cancer	4.39e-05	0.000695	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—CDK4—brain cancer	4.28e-05	0.000678	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—CDK4—brain cancer	4.28e-05	0.000678	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.16e-05	0.000658	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	4.12e-05	0.000653	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.07e-05	0.000644	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.07e-05	0.000644	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—RELA—brain cancer	4.03e-05	0.000638	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.02e-05	0.000637	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	3.98e-05	0.000631	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—ENO2—brain cancer	3.85e-05	0.00061	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—CTNNB1—brain cancer	3.82e-05	0.000605	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.81e-05	0.000603	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.77e-05	0.000597	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	3.76e-05	0.000596	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.75e-05	0.000593	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CYP2C9—brain cancer	3.74e-05	0.000592	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.68e-05	0.000582	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—IL2—brain cancer	3.63e-05	0.000575	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.49e-05	0.000553	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.47e-05	0.00055	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3.39e-05	0.000537	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—VEGFA—brain cancer	3.38e-05	0.000535	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—VEGFA—brain cancer	3.38e-05	0.000535	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—STAT3—brain cancer	3.33e-05	0.000527	CbGpPWpGaD
Propofol—ALB—Hemostasis—BSG—brain cancer	3.24e-05	0.000514	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.21e-05	0.000509	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—RELA—brain cancer	3.2e-05	0.000507	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—BSG—brain cancer	3.18e-05	0.000503	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—RELA—brain cancer	3.15e-05	0.000499	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—RELA—brain cancer	3.15e-05	0.000499	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—ERBB2—brain cancer	3.13e-05	0.000496	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—ERBB2—brain cancer	3.13e-05	0.000496	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.12e-05	0.000494	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	3.09e-05	0.000489	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.08e-05	0.000487	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—EGFR—brain cancer	3.04e-05	0.000482	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—EGFR—brain cancer	3.04e-05	0.000482	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CYP2C9—brain cancer	2.95e-05	0.000468	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CYP2C9—brain cancer	2.95e-05	0.000468	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.88e-05	0.000456	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.79e-05	0.000441	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CYP2C9—brain cancer	2.75e-05	0.000436	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—CTNNB1—brain cancer	2.74e-05	0.000434	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—CTNNB1—brain cancer	2.74e-05	0.000434	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—IDH1—brain cancer	2.73e-05	0.000433	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.71e-05	0.000429	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.65e-05	0.00042	CbGpPWpGaD
Propofol—ALB—Platelet degranulation—VEGFA—brain cancer	2.65e-05	0.000419	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.59e-05	0.000411	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.59e-05	0.000411	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.55e-05	0.000404	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.54e-05	0.000402	CbGpPWpGaD
Propofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	2.52e-05	0.000399	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—BSG—brain cancer	2.51e-05	0.000398	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—BSG—brain cancer	2.51e-05	0.000398	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.43e-05	0.000385	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PIK3CG—brain cancer	2.42e-05	0.000383	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—VEGFA—brain cancer	2.41e-05	0.000382	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—VEGFA—brain cancer	2.41e-05	0.000382	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—STAT3—brain cancer	2.39e-05	0.000378	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—STAT3—brain cancer	2.39e-05	0.000378	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—BSG—brain cancer	2.34e-05	0.000371	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—TP53—brain cancer	2.33e-05	0.000369	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.28e-05	0.000361	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CYP2C9—brain cancer	2.28e-05	0.000361	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—EGFR—brain cancer	2.17e-05	0.000344	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—EGFR—brain cancer	2.17e-05	0.000344	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—IDH1—brain cancer	2.16e-05	0.000342	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—ENO2—brain cancer	2.16e-05	0.000342	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—IDH1—brain cancer	2.16e-05	0.000342	CbGpPWpGaD
Propofol—ALB—Hemostasis—TRPC6—brain cancer	2.13e-05	0.000337	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.08e-05	0.000329	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—IDH1—brain cancer	2.01e-05	0.000319	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	1.96e-05	0.000311	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—BSG—brain cancer	1.94e-05	0.000307	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	1.84e-05	0.000291	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP2C9—brain cancer	1.84e-05	0.000291	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP2C9—brain cancer	1.8e-05	0.000285	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.78e-05	0.000281	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PIK3CG—brain cancer	1.77e-05	0.00028	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.76e-05	0.000278	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—ENO2—brain cancer	1.71e-05	0.00027	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—ENO2—brain cancer	1.71e-05	0.00027	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CYP2C9—brain cancer	1.7e-05	0.000269	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—IDH1—brain cancer	1.66e-05	0.000264	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.64e-05	0.00026	CbGpPWpGaD
Propofol—ALB—Hemostasis—VAV1—brain cancer	1.59e-05	0.000252	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—ENO2—brain cancer	1.59e-05	0.000252	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—BSG—brain cancer	1.56e-05	0.000247	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP2C9—brain cancer	1.56e-05	0.000246	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP2C9—brain cancer	1.55e-05	0.000245	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—BSG—brain cancer	1.53e-05	0.000242	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—BSG—brain cancer	1.44e-05	0.000228	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP2C9—brain cancer	1.39e-05	0.00022	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	1.38e-05	0.000219	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—IDH1—brain cancer	1.34e-05	0.000213	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—BSG—brain cancer	1.32e-05	0.000209	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ENO2—brain cancer	1.32e-05	0.000208	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—IDH1—brain cancer	1.32e-05	0.000208	CbGpPWpGaD
Propofol—ALB—Metabolism—BSG—brain cancer	1.31e-05	0.000208	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP2C9—brain cancer	1.28e-05	0.000202	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—IDH1—brain cancer	1.24e-05	0.000196	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—BSG—brain cancer	1.18e-05	0.000187	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.17e-05	0.000186	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—IDH1—brain cancer	1.14e-05	0.00018	CbGpPWpGaD
Propofol—ALB—Metabolism—IDH1—brain cancer	1.13e-05	0.000179	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—BSG—brain cancer	1.09e-05	0.000172	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP2C9—brain cancer	1.08e-05	0.000171	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—BSG—brain cancer	1.08e-05	0.00017	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ENO2—brain cancer	1.06e-05	0.000168	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ENO2—brain cancer	1.04e-05	0.000165	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—IDH1—brain cancer	1.02e-05	0.000161	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CG—brain cancer	1.01e-05	0.00016	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.01e-05	0.00016	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CG—brain cancer	9.91e-06	0.000157	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ENO2—brain cancer	9.81e-06	0.000155	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—IDH1—brain cancer	9.34e-06	0.000148	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.26e-06	0.000147	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—IDH1—brain cancer	9.26e-06	0.000147	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.21e-06	0.000146	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—BSG—brain cancer	9.2e-06	0.000146	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ENO2—brain cancer	8.99e-06	0.000142	CbGpPWpGaD
Propofol—ALB—Metabolism—ENO2—brain cancer	8.94e-06	0.000142	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP2C9—brain cancer	8.35e-06	0.000132	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.26e-06	0.000131	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ENO2—brain cancer	8.02e-06	0.000127	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—IDH1—brain cancer	7.91e-06	0.000125	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CG—brain cancer	7.83e-06	0.000124	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CG—brain cancer	7.83e-06	0.000124	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.54e-06	0.000119	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ENO2—brain cancer	7.38e-06	0.000117	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ENO2—brain cancer	7.32e-06	0.000116	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CG—brain cancer	7.3e-06	0.000116	CbGpPWpGaD
Propofol—ALB—Hemostasis—IL2—brain cancer	7.12e-06	0.000113	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—BSG—brain cancer	7.1e-06	0.000112	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.44e-06	0.000102	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ENO2—brain cancer	6.25e-06	9.9e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—IDH1—brain cancer	6.1e-06	9.67e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—brain cancer	6.05e-06	9.58e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CG—brain cancer	6.04e-06	9.56e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CG—brain cancer	4.87e-06	7.71e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ENO2—brain cancer	4.82e-06	7.64e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CG—brain cancer	4.77e-06	7.56e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—brain cancer	4.57e-06	7.24e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CG—brain cancer	4.5e-06	7.12e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CG—brain cancer	4.12e-06	6.53e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CG—brain cancer	4.1e-06	6.49e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CG—brain cancer	3.68e-06	5.83e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CG—brain cancer	3.39e-06	5.36e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CG—brain cancer	3.36e-06	5.31e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CG—brain cancer	2.87e-06	4.54e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CG—brain cancer	2.21e-06	3.51e-05	CbGpPWpGaD
